Sexual dimorphism in a mouse model of Friedreich's ataxia with severe cardiomyopathy

被引:0
|
作者
Salinas, Lili [1 ]
Montgomery, Claire B. [1 ]
Figueroa, Francisco [1 ]
Thai, Phung N. [2 ,3 ]
Chiamvimonvat, Nipavan [2 ,3 ]
Cortopassi, Gino [1 ]
Dedkova, Elena N. [1 ,4 ]
机构
[1] Univ Calif Davis, Dept Mol Biosci, Davis, CA 95616 USA
[2] Univ Calif Davis, Dept Internal Med, Davis, CA USA
[3] Northern Calif Hlth Care Syst, Dept Vet Affairs, Mather, CA USA
[4] Calif Northstate Univ, Dept Basic Sci, Elk Grove, CA 95757 USA
关键词
DISEASE; HEART; ESTROGEN; PROTEIN; RECEPTOR; STEROIDOGENESIS; OMAVELOXOLONE; TESTOSTERONE; CHOLESTEROL; EXPRESSION;
D O I
10.1038/s42003-024-06962-4
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Friedreich's ataxia (FA) is an autosomal recessive disorder caused by reduced frataxin (FXN) expression in mitochondria, where the lethal component is cardiomyopathy. Using the conditional Fxnflox/null::MCK-Cre knock-out (Fxn-cKO) mouse model, we discovered significant sex differences in the progression towards heart failure, with Fxn-cKO males exhibiting a worse cardiac phenotype, low survival rate, kidney and reproductive organ deficiencies. These differences are likely due to a decline in testosterone in Fxn-cKO males. The decrease in testosterone was related to decreased expression of proteins involved in cholesterol transfer into the mitochondria: StAR and TSPO on the outer mitochondrial membrane, and the cholesterol side-chain cleavage enzyme P450scc and ferredoxin on the inner mitochondrial membrane. Expression of excitation-contraction coupling proteins (L-type calcium channel, RyR2, SERCA2, phospholamban and CaMKII delta) was decreased significantly more in Fxn-cKO males. This is the first study that extensively investigates the sexual dimorphism in FA mouse model with cardiac calcium signaling impairment. Sexual dimorphism is identified in a mouse model of Friedreich's ataxia, with males exhibiting a worse cardiac phenotype, low survival rate, as well as kidney and reproductive organ deficiencies.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Phosphodiesterase Inhibitors Revert Axonal Dystrophy in Friedreich's Ataxia Mouse Model
    Molla, Belen
    Munoz-Lasso, Diana C.
    Calap, Pablo
    Fernandez-Vilata, Angel
    de la Iglesia-Vaya, Maria
    Pallardo, Federico V.
    Dolores Molto, Maria
    Palau, Francesc
    Gonzalez-Cabo, Pilar
    NEUROTHERAPEUTICS, 2019, 16 (02) : 432 - 449
  • [32] Cerebellar Pathology in an Inducible Mouse Model of Friedreich Ataxia
    Mercado-Ayon, Elizabeth
    Warren, Nathan
    Halawani, Sarah
    Rodden, Layne N.
    Ngaba, Lucie
    Dong, Yi Na
    Chang, Joshua C.
    Fonck, Carlos
    Mavilio, Fulvio
    Lynch, David R.
    Lin, Hong
    FRONTIERS IN NEUROSCIENCE, 2022, 16
  • [33] Effect of idebenone on cardiomyopathy in Friedreich's ataxia:: a preliminary study
    Rustin, P
    von Kleist-Retzow, JC
    Chantrel-Groussard, K
    Sidi, D
    Munnich, A
    Rötig, A
    LANCET, 1999, 354 (9177): : 477 - 479
  • [34] Epigenetic silencing in the humanized mouse model of Friedreich ataxia
    Rodden, L.
    Gilliam, K.
    Bidichandani, S.
    MOVEMENT DISORDERS, 2018, 33 : S55 - S55
  • [35] AAV gene therapy to treat Friedreich's ataxia cardiomyopathy
    Ferreira, Jorge
    LAB ANIMAL, 2024, 53 (04) : 86 - 86
  • [36] Clinical features and progression of cardiomyopathy in patients with Friedreich's ataxia
    Pureza, Vincent
    Hasadsri, Linda
    Highsmith, W. Edward
    Oglesbee, Devin
    MITOCHONDRION, 2013, 13 (06) : 925 - 925
  • [37] AAV gene therapy to treat Friedreich’s ataxia cardiomyopathy
    Jorge Ferreira
    Lab Animal, 2024, 53 : 86 - 86
  • [38] Friedreich's Ataxia and Hypertrophic Cardiomyopathy: A Case Report and Review
    Benhalla, Hanane
    Sorea, Camelia
    IRANIAN HEART JOURNAL, 2015, 16 (04): : 57 - 59
  • [39] The Longitudinal Course of Cardiomyopathy in Friedreich's Ataxia During Childhood
    Kipps, Alaina
    Alexander, Mark
    Colan, Steven D.
    Gauvreau, Kimberlee
    Smoot, Leslie
    Crawford, Lisa
    Darras, Basil T.
    Blume, Elizabeth D.
    PEDIATRIC CARDIOLOGY, 2009, 30 (03) : 306 - 310
  • [40] Cytokine therapy-mediated neuroprotection in a Friedreich's ataxia mouse model
    Kemp, Kevin C.
    Cerminara, Nadia
    Hares, Kelly
    Redondo, Juliana
    Cook, Amelia J.
    Haynes, Harry R.
    Burton, Bronwen R.
    Pook, Mark
    Apps, Richard
    Scolding, Neil J.
    Wilkins, Alastair
    ANNALS OF NEUROLOGY, 2017, 81 (02) : 212 - 226